
The FDA recently approved durvalumab (Imfinzi) for the treatment of patients with stage 3 non-small cell lung cancer (NSCLC) whose tumors are unresectable and whose disease has not progressed following treatment with chemoradiation.

The FDA recently approved durvalumab (Imfinzi) for the treatment of patients with stage 3 non-small cell lung cancer (NSCLC) whose tumors are unresectable and whose disease has not progressed following treatment with chemoradiation.

A follow up to part one, we learn more about what comes after the third professional year of pharmacy school and beyond

QVAR RediHaler is now commercially available to patients by prescription in 40 mcg and 80 mcg strengths.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Pharmacists can play an important role in educating families about poison prevention.

Tissue Plasminogen Activator (tPA) is administered in patients with Acute Ischemic Stroke. Becuase tPA administration is time sensitive, caution is required.

The Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA) have released updated guidelines for Clostridium difficile infections.

A new study published in the Annals of Internal Medicine this week suggests that opioids may pose a different, unintended untoward consequence in patients: an increased risk of pneumococcal infection.



As the job market for pharmacists becomes more competitive, many pharmacists are turning to credentialing as a way to distinguish themselves professionally.

Migraines may be an important risk factor for several cardiovascular diseases, apart from stroke and heart attacks.

February is American Heart Month.

FDA officials have approved tezacaftor/ivacaftor and ivacaftor (Symdeko, Vertex Pharmaceuticals) for the treatment of cystic fibrosis (CF) in individuals aged 12 years and older.

Officials with the FDA have approved Novartis' glatiramer acetate injection (Glatopa) 40-mg/mL for the treatment of multiple sclerosis (MS).

Adults over the age of 65 are increasingly more active on Facebook, especially when it comes to health information.

This is the fourth part of a series on how pharmacy professionals have been depicted on TV, both in a positive and negative manner.

Dr. Timothy Burke provides insight into this nontraditional field.

After completing a drug information residency, pharmacists may wonder what career opportunities are available.

Antibiotics may become ineffective in treating E coli if antibiotic resistance continues to increase among children.

Pharmacists rank fifth among the most honest and ethical professionals in the United States, according to the latest Gallup poll.

Researchers from the CDC assessed adverse effects (AEs) following HepB vaccinations using the Vaccine Adverse Event Reporting System (VAERS).

Influenza activity is breaking recent records this season, and is not yet slowing down, according to the CDC.

The 2017-2018 influenza season is the worst in recent history.

Pharmacists have once again been ranked among the most honest and ethical professionals in the United States, according to the results of the latest Gallup poll on the topic.

Although researchers have conducted no clinical trials to evaluate the vocal benefits of vitamin B12, the singing community at large endorses the energy boosting and anxiety fighting effects of the supplement.

An innovate production method may allow health care providers to produce on-demand medicine in the near future.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The provision of evidence-based medication recommendations is an important role for pharmacists.

Officials with the FDA have granted approval to abiraterone acetate (Zytiga) tablets in combination with prednisone for the treatment of metastatic high-risk castration-sensitive prostate cancer (CSPC), according to a press release.